Explore
Trendline
ADC Therapeutics Announces Upcoming Financial Results Conference Call for Q1 2026
ADC Therapeutics Announces Upcoming Financial Results Conference Call for Q1 2026
Read More
Trendline
ADC Therapeutics Announces First Quarter 2026 Financial Results Call
ADC Therapeutics Announces First Quarter 2026 Financial Results Call
Read More
Trendline
Ituran Location and Control Ltd. Announces Q1 2026 Results Release
Ituran Location and Control Ltd. Announces Q1 2026 Results Release
Read More
Trendline
Vir Biotechnology Announces Upcoming Conference Call for Q1 2026 Financial Results
Vir Biotechnology Announces Upcoming Conference Call for Q1 2026 Financial Results
Read More
Trendline
Vir Biotechnology Announces Upcoming Financial Results Conference Call
Vir Biotechnology Announces Upcoming Financial Results Conference Call
Read More
Trendline
Personalis to Release Q1 2026 Financial Results, Highlighting Precision Oncology Advances
Personalis to Release Q1 2026 Financial Results, Highlighting Precision Oncology Advances
Read More
Trendline
Xeris Biopharma to Announce Q1 2026 Financial Results with Conference Call
Xeris Biopharma to Announce Q1 2026 Financial Results with Conference Call
Read More
Trendline
Alpha Metallurgical Resources Reports Preliminary Q1 2026 Financial Results Amid Challenges
Alpha Metallurgical Resources Reports Preliminary Q1 2026 Financial Results Amid Challenges
Read More
Trendline
Norfolk Southern Reports Q1 2026 Financial Results Highlighting Safety and Cost Control
Norfolk Southern Reports Q1 2026 Financial Results Highlighting Safety and Cost Control
Read More
Trendline
Sensient Technologies Reports Strong Q1 2026 Financial Results with Revenue Growth
Sensient Technologies Reports Strong Q1 2026 Financial Results with Revenue Growth
Read More
Trendline
Teledyne Technologies Reports Strong Q1 2026 Financial Results
Teledyne Technologies Reports Strong Q1 2026 Financial Results
Read More
Trendline
Verastem Oncology to Announce Q1 2026 Financial Results Amid Cancer Drug Development
Verastem Oncology to Announce Q1 2026 Financial Results Amid Cancer Drug Development
Read More
